<DOC>
	<DOCNO>NCT00932867</DOCNO>
	<brief_summary>Surveillance efficacy safety drug PRITOR patieNts arterial hypertension , tolerate ACE inhibitoR treatment</brief_summary>
	<brief_title>Surveillance Efficacy Safety Drug PRITOR patieNts With Arterial Hypertension , Who Not Tolerate ACE inhibitoR Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients 18 year age Arterial hypertension ( SBP &lt; 160 mmHg DBP &lt; 100 mmHg ) Patients , tolerate ACE inhibitor ( must document official ambulant documentation ) Inclusion criterion control arm ( treated ACEi ) : Patients 18 year age Arterial hypertension ( SBP &lt; 160 mmHg DBP &lt; 100 mmHg ) Patients , tolerate ACEi treatment Cholestasis , severe hepatic insufficiency Allergy telmisartan Gravidity lactation Exclusion criterion arm patient treat ACEi : Cholestasis , severe hepatic insufficiency Allergy ACEi Gravidity lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Arterial Hypertension</keyword>
</DOC>